Cinnamon (Ceylon vs Cassia)

Cinnamomum verum (Ceylon) / Cinnamomum cassia (Cassia)
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Cinnamon is the dried inner bark of Cinnamomum trees — two main supplement species: Ceylon (C. verum, 'true cinnamon', sweeter, lower coumarin) and cassia (C. cassia, more common in supplements and grocery stores, higher coumarin). Used for blood sugar/diabetes support. Critical distinction: cassia cinnamon has high coumarin content that can cause hepatotoxicity at high chronic doses — Ceylon is preferred for supplemental/medicinal use.

Studied Dose 1-6 g/day cinnamon powder; 250-500 mg/day water-soluble extract (Cinnulin PF® standardized); typically 1-2 g daily
Active Compound Cinnamaldehyde, cinnamic acid, MHCP (methyl hydroxychalcone polymer), procyanidins; coumarin (in cassia)

Benefits

Modest Blood Glucose Reduction (T2DM)

Multiple meta-analyses show cinnamon (1-6 g/day) modestly reduces fasting glucose (~10-29 mg/dL) and HbA1c in T2DM patients. Effect is modest and inconsistent across trials. Standard diabetes management (metformin, lifestyle, GLP-1 agonists) remains foundational.

Insulin Sensitivity Improvement

Cinnamon may modestly improve insulin sensitivity via multiple mechanisms — most studied in metabolic syndrome and prediabetes contexts. MHCP compound shown to mimic insulin in vitro. Human translation modest.

Lipid Modest Improvement

Some trials show cinnamon reduces total cholesterol and LDL modestly. Effect inconsistent and substantially weaker than statins or other evidence-based lipid agents.

Antimicrobial / Anti-Fungal

Cinnamaldehyde has broad antimicrobial activity — used in oral care products, food preservation. Topical/oral use modest evidence for oral health.

Anti-Inflammatory / Antioxidant

Procyanidins and other polyphenols in cinnamon have antioxidant activity. Modest anti-inflammatory effects in some markers.

Mechanism of action

1

Insulin-Mimetic / Sensitizing Effects

MHCP (methyl hydroxychalcone polymer) and other cinnamon compounds activate insulin receptor and downstream signaling — modestly mimicking insulin and improving sensitivity. Animal evidence stronger than human.

2

Glucose Transporter Effects

Cinnamon may enhance glucose uptake into peripheral tissues via GLUT4 modulation — similar mechanism to exercise and insulin. Modest effect.

3

Alpha-Glucosidase Inhibition

Cinnamon polyphenols modestly inhibit intestinal alpha-glucosidase — reducing post-prandial glucose spikes. Similar mechanism to acarbose (prescription diabetes drug).

4

Coumarin Hepatotoxicity (Cassia)

Cassia cinnamon contains coumarin at levels (5,000-10,000 mg/kg dry weight) that can cause hepatotoxicity at chronic high doses. Ceylon cinnamon contains <250 mg/kg coumarin. EFSA TDI for coumarin: 0.1 mg/kg body weight/day. Heavy daily Cassia consumption (1-2 tsp+ daily) can exceed safe coumarin intake.

Clinical trials

1
Cinnamon for Type 2 Diabetes

Pooled analysis of cinnamon (various forms and doses) for T2DM glycemic control.

Pooled across T2DM clinical trials.

Cinnamon modestly reduced fasting glucose (~24 mg/dL), total cholesterol, LDL. Effect on HbA1c modest and not consistent. Effect size smaller than metformin or other established diabetes therapies.

2
Cinnamon for Glycemic Control

Evidence review of cinnamon supplementation for T2DM —

Pooled across T2DM clinical trials.

Modest glycemic effects across trials but high heterogeneity. Some trials positive, others negative. Standard T2DM management primary; cinnamon adjunctive at most.

Side effects and drug interactions

Common Potential side effects

GI distress (heartburn, nausea, mouth/lip irritation).
Mouth sores / oral irritation — particularly with 'cinnamon challenge' or high cinnamon contact.
Hepatotoxicity from cassia cinnamon's coumarin content — chronic high doses (>1-2 tsp daily); reversible if discontinued.
Allergic reactions / contact dermatitis.
Hypoglycemia in diabetics on insulin/sulfonylureas.
Bleeding risk at high doses (theoretical; cinnamon has mild antiplatelet effects).
Theobromine-like stimulating effects in some sensitive individuals.

Important Drug interactions

Diabetes medications (metformin, insulin, sulfonylureas) — additive hypoglycemic effects; monitor blood glucose.
Anticoagulants — modest theoretical bleeding risk at high doses; monitor.
Hepatotoxic drugs — additive liver toxicity risk with chronic high-dose Cassia.
CYP-metabolized drugs — cinnamon may modestly affect CYP enzymes; theoretical interactions.
Antihypertensives — possible additive BP reduction.

Frequently asked questions about Cinnamon (Ceylon vs Cassia)

How much cinnamon should I take?

Studies on blood sugar commonly use about 1 to 6 grams of cinnamon per day; concentrated extracts use less. Culinary amounts sprinkled on food also contribute, though usually below the studied doses.

What is cinnamon used for as a supplement?

Cinnamon is most studied for supporting healthy blood sugar and for modest effects on cholesterol. Its compounds may improve how the body responds to insulin. It is also valued as an antioxidant-rich spice.

Ceylon or cassia cinnamon, which is safer?

Most grocery-store cinnamon is cassia, which contains coumarin, a compound that can stress the liver in large daily amounts. Ceylon (true) cinnamon is very low in coumarin and is the safer choice for regular supplemental use.

Is it safe to take cinnamon supplements daily?

Culinary use is fine for nearly everyone. For daily supplemental doses, choose Ceylon cinnamon to limit coumarin, especially if combining with diabetes medication (monitor blood sugar) or if you have liver concerns. Check with your doctor if relevant.

What is Cinnamon?

Cinnamon is the dried inner bark of Cinnamomum trees — two main supplement species: Ceylon (C. verum, 'true cinnamon', sweeter, lower coumarin) and cassia (C. cassia, more common in supplements and grocery stores, higher coumarin). Used for blood sugar/diabetes support.

What is Cinnamon used for?

Cinnamon is researched primarily for Metabolic Health and Anti-Inflammatory. Multiple meta-analyses show cinnamon (1-6 g/day) modestly reduces fasting glucose (~10-29 mg/dL) and HbA1c in T2DM patients. Effect is modest and inconsistent across trials.

What is the recommended dosage of Cinnamon?

The clinically studied dose is 1-6 g/day cinnamon powder; 250-500 mg/day water-soluble extract (Cinnulin PF® standardized); typically 1-2 g daily Always follow the product label and check with a healthcare provider for personal advice.

Is Cinnamon safe, and does it have side effects?

For most healthy adults, Cinnamon is well tolerated at studied doses. Reported effects can include: GI distress (heartburn, nausea, mouth/lip irritation). Mouth sores / oral irritation — particularly with 'cinnamon challenge' or high cinnamon contact. It may also interact with some medications. Cinnamon is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Cinnamon interact with any medications?

Possible interactions include: Diabetes medications (metformin, insulin, sulfonylureas) — additive hypoglycemic effects; monitor blood glucose. Anticoagulants — modest theoretical bleeding risk at high doses; monitor. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Cinnamon?

NutraSmarts rates the evidence for Cinnamon as Moderate (3 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Moridpour AH, Kavyani Z, Khosravi S, et al. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2024;38(1):117-130..PubMedUsed to support: Dose-response meta-analysis supporting cinnamon for glycemic control in type 2 diabetes.